South Indian Bank has closed its trading window for securities from October 1, 2026. The closure remains in effect until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026.

This action is taken pursuant to Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The bank's internal Code of Conduct for Prevention of Insider Trading mandates this blackout period to prevent misuse of unpublished price-sensitive information.

Restrictions on trading

During the closed period, no trading in the bank's securities is permitted by:

• Directors of the bank
• Connected persons
• Designated employees
• Immediate relatives of the above individuals

The definition of these groups aligns with the bank's approved Code of Conduct. The trading window opened on the quarter-end date and will reopen only after the specified post-declaration period.

Board meeting schedule

The date for the board meeting to approve the unaudited financial results for the quarter ending September 30, 2026, has not yet been announced. The company secretary stated that this date will be intimated to stock exchanges in due course.

The filing was digitally signed by Jimmy Mathew, Company Secretary, on September 25, 2026.

South Indian Bank granted 5,30,916 employee stock ownership scheme (ESOS) options to Managing Director & CEO P R Seshadri on September 25, 2026. The grant complies with Reserve Bank of India (RBI) approval for non-cash variable pay for FY26.

The options were issued under the SIB ESOS Scheme 2008 and recommended by the Nomination and Remuneration Committee. No options were granted to the Part-time Chairman or other Non-Executive Directors. The Board meeting commenced at 10:30 am and concluded at 6:30 pm.

Option pricing and vesting structure

The exercise price is set at ₹23.54 per share, representing a 50% discount on the market price of ₹47.08 recorded on September 23, 2026. An option premium of ₹32.72 per option was determined using the Black Scholes Model by a registered valuer.

Vesting follows a staggered timeline over three years:

What the numbers show

The grant represents a significant dilution potential relative to the current share price. With an exercise price of ₹23.54 against a closing market price of ₹47.08, the intrinsic value at grant is substantial. However, the high option premium of ₹32.72 indicates that the fair value of the benefit is heavily weighted toward time value rather than immediate intrinsic gain, aligning with long-term retention goals.

Regulatory compliance and details

The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and adheres to SEBI Master Circular dated January 30, 2026. The options may be exercised within five years from the respective vesting dates. If exercised fully, the grant will result in the issuance of 5,30,916 equity shares with a face value of ₹1 each.